Transcriptional Regulation in Non-Alcoholic Fatty Liver Disease
Open Access
- 9 July 2020
- journal article
- review article
- Published by MDPI AG in Metabolites
- Vol. 10 (7) , 283
Abstract
Obesity is the primary risk factor for the pathogenesis of non-alcoholic fatty liver disease (NAFLD), the worldwide prevalence of which continues to increase dramatically. The liver plays a pivotal role in the maintenance of whole-body lipid and glucose homeostasis. This is mainly mediated by the transcriptional activation of hepatic pathways that promote glucose and lipid production or utilization in response to the nutritional state of the body. However, in the setting of chronic excessive nutrition, the dysregulation of hepatic transcriptional machinery promotes lipid accumulation, inflammation, metabolic stress, and fibrosis, which culminate in NAFLD. In this review, we provide our current understanding of the transcription factors that have been linked to the pathogenesis and progression of NAFLD. Using publicly available transcriptomic data, we outline the altered activity of transcription factors among humans with NAFLD. By expanding this analysis to common experimental mouse models of NAFLD, we outline the relevance of mouse models to the human pathophysiology at the transcriptional level.Keywords
This publication has 217 references indexed in Scilit:
- Identification of a Mitochondrial Target of Thiazolidinedione Insulin Sensitizers (mTOT)—Relationship to Newly Identified Mitochondrial Pyruvate Carrier ProteinsPLOS ONE, 2013
- Regulation of cytochrome P450 2e1 expression by ethanol: role of oxidative stress-mediated pkc/jnk/sp1 pathwayCell Death & Disease, 2013
- A novel ChREBP isoform in adipose tissue regulates systemic glucose metabolismNature, 2012
- Endoplasmic reticulum-tethered transcription factor cAMP responsive element-binding protein, hepatocyte specific, regulates hepatic lipogenesis, fatty acid oxidation, and lipolysis upon metabolic stress in miceHepatology, 2011
- The transcription factor cyclic AMP–responsive element–binding protein H regulates triglyceride metabolismNature Medicine, 2011
- The unfolded protein response transducer IRE1α prevents ER stress‐induced hepatic steatosisThe EMBO Journal, 2011
- Prevention of Hepatic Steatosis and Hepatic Insulin Resistance by Knockdown of cAMP Response Element-Binding ProteinCell Metabolism, 2009
- Activation of nuclear receptor CAR ameliorates diabetes and fatty liver diseaseProceedings of the National Academy of Sciences, 2009
- The Constitutive Androstane Receptor Is an Anti-obesity Nuclear Receptor That Improves Insulin SensitivityJournal of Biological Chemistry, 2009
- Functional and comparative metagenomic analysis of bile salt hydrolase activity in the human gut microbiomeProceedings of the National Academy of Sciences, 2008